Phase 4
18 Years
65 Years
18 Years
65 Years
Open (Enrolling)
Both
Profound Muscle Relaxation, Muscle Trauma, Postoperative Analgesic Demand, Postoperative Pulmonary Function
Both
Profound Muscle Relaxation, Muscle Trauma, Postoperative Analgesic Demand, Postoperative Pulmonary Function
Trial Information
Inclusion Criteria:
- ASA 1~2,scheduled to undergo upper abdominal surgery by midline incision
Exclusion Criteria:
- neuromuscular disorder
- history of malignant hyperthemia
- allergy to medications used during general anesthesia
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
degree of muscle trauma
Outcome Description:
serum CK
Outcome Time Frame:
72h postoperatively
Safety Issue:
No
Principal Investigator
Ying Xiao, MD, PhD
Investigator Role:
Study Director
Investigator Affiliation:
First Affiliated Hospital, Sun Yat-Sen University
Authority:
China: Food and Drug Administration
Study ID:
伦审[2012]326号
NCT ID:
NCT01804933
Start Date:
July 2012
Completion Date:
August 2013
Related Keywords:
- Profound Muscle Relaxation
- Muscle Trauma
- Postoperative Analgesic Demand
- Postoperative Pulmonary Function
- profound muscle relaxation
- muscle trauma
- postoperative analgesic demand
- postoperative pulmonary function
- Muscle Hypotonia
- Wounds and Injuries
Name | Location |
|---|
